Orient Cement Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: December 4, 2025, 1:29 am

Competitors of Orient Cement Ltd

All Competitor Stocks of Orient Cement Ltd

Quarterly Result

Last Updated: August 1, 2025, 4:05 pm

Below is a detailed analysis of the quarterly data for Orient Cement Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 866.00 Cr.. The value appears strong and on an upward trend. It has increased from 825.00 Cr. (Mar 2025) to 866.00 Cr., marking an increase of 41.00 Cr..
• For Expenses, as of Jun 2025, the value is 684.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 722.00 Cr. (Mar 2025) to 684.00 Cr., marking a decrease of 38.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 183.00 Cr.. The value appears strong and on an upward trend. It has increased from 103.00 Cr. (Mar 2025) to 183.00 Cr., marking an increase of 80.00 Cr..
• For OPM %, as of Jun 2025, the value is 21.00%. The value appears strong and on an upward trend. It has increased from 12.00% (Mar 2025) to 21.00%, marking an increase of 9.00%.
• For Other Income, as of Jun 2025, the value is 2.00 Cr.. The value appears to be declining and may need further review. It has decreased from 8.00 Cr. (Mar 2025) to 2.00 Cr., marking a decrease of 6.00 Cr..
• For Interest, as of Jun 2025, the value is 3.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 6.00 Cr. (Mar 2025) to 3.00 Cr., marking a decrease of 3.00 Cr..
• For Depreciation, as of Jun 2025, the value is 37.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 37.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 144.00 Cr.. The value appears strong and on an upward trend. It has increased from 68.00 Cr. (Mar 2025) to 144.00 Cr., marking an increase of 76.00 Cr..
• For Tax %, as of Jun 2025, the value is -42.00%. The value appears to be improving (decreasing) as expected. It has decreased from 38.00% (Mar 2025) to -42.00%, marking a decrease of 80.00%.
• For Net Profit, as of Jun 2025, the value is 205.00 Cr.. The value appears strong and on an upward trend. It has increased from 42.00 Cr. (Mar 2025) to 205.00 Cr., marking an increase of 163.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 10.00. The value appears strong and on an upward trend. It has increased from 2.05 (Mar 2025) to 10.00, marking an increase of 7.95.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: August 23, 2025, 2:20 pm

Growth

Last Updated: September 5, 2025, 12:00 pm

Balance Sheet

Last Updated: December 4, 2025, 1:45 am

Below is a detailed analysis of the balance sheet data for Orient Cement Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

• For Equity Capital, as of Sep 2025, the value is 21.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 21.00 Cr..
• For Reserves, as of Sep 2025, the value is 2,042.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,787.00 Cr. (Mar 2025) to 2,042.00 Cr., marking an increase of 255.00 Cr..
• For Borrowings, as of Sep 2025, the value is 72.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 70.00 Cr. (Mar 2025) to 72.00 Cr., marking an increase of 2.00 Cr..
• For Other Liabilities, as of Sep 2025, the value is 829.00 Cr.. The value appears to be improving (decreasing). It has decreased from 925.00 Cr. (Mar 2025) to 829.00 Cr., marking a decrease of 96.00 Cr..
• For Total Liabilities, as of Sep 2025, the value is 2,963.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,803.00 Cr. (Mar 2025) to 2,963.00 Cr., marking an increase of 160.00 Cr..
• For Fixed Assets, as of Sep 2025, the value is 1,864.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,990.00 Cr. (Mar 2025) to 1,864.00 Cr., marking a decrease of 126.00 Cr..
• For CWIP, as of Sep 2025, the value is 28.00 Cr.. The value appears strong and on an upward trend. It has increased from 24.00 Cr. (Mar 2025) to 28.00 Cr., marking an increase of 4.00 Cr..
• For Investments, as of Sep 2025, the value is 13.00 Cr.. The value appears to be declining and may need further review. It has decreased from 42.00 Cr. (Mar 2025) to 13.00 Cr., marking a decrease of 29.00 Cr..
• For Other Assets, as of Sep 2025, the value is 1,059.00 Cr.. The value appears strong and on an upward trend. It has increased from 746.00 Cr. (Mar 2025) to 1,059.00 Cr., marking an increase of 313.00 Cr..
• For Total Assets, as of Sep 2025, the value is 2,963.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,803.00 Cr. (Mar 2025) to 2,963.00 Cr., marking an increase of 160.00 Cr..

Notably, the Reserves (2,042.00 Cr.) exceed the Borrowings (72.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Orient Cement Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 4.45. This value is below the healthy minimum of 5. It has decreased from 8.53 (Mar 24) to 4.45, marking a decrease of 4.08.
• For Diluted EPS (Rs.), as of Mar 25, the value is 4.45. This value is below the healthy minimum of 5. It has decreased from 8.53 (Mar 24) to 4.45, marking a decrease of 4.08.
• For Cash EPS (Rs.), as of Mar 25, the value is 11.91. This value is within the healthy range. It has decreased from 15.82 (Mar 24) to 11.91, marking a decrease of 3.91.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 88.14. It has increased from 85.09 (Mar 24) to 88.14, marking an increase of 3.05.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 88.14. It has increased from 85.09 (Mar 24) to 88.14, marking an increase of 3.05.
• For Dividend / Share (Rs.), as of Mar 25, the value is 0.50. This value is below the healthy minimum of 1. It has decreased from 2.25 (Mar 24) to 0.50, marking a decrease of 1.75.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 132.07. It has decreased from 155.47 (Mar 24) to 132.07, marking a decrease of 23.40.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 15.66. This value is within the healthy range. It has decreased from 22.69 (Mar 24) to 15.66, marking a decrease of 7.03.
• For PBIT / Share (Rs.), as of Mar 25, the value is 8.20. This value is within the healthy range. It has decreased from 15.40 (Mar 24) to 8.20, marking a decrease of 7.20.
• For PBT / Share (Rs.), as of Mar 25, the value is 7.09. This value is within the healthy range. It has decreased from 13.74 (Mar 24) to 7.09, marking a decrease of 6.65.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 4.45. This value is within the healthy range. It has decreased from 8.53 (Mar 24) to 4.45, marking a decrease of 4.08.
• For PBDIT Margin (%), as of Mar 25, the value is 11.85. This value is within the healthy range. It has decreased from 14.59 (Mar 24) to 11.85, marking a decrease of 2.74.
• For PBIT Margin (%), as of Mar 25, the value is 6.20. This value is below the healthy minimum of 10. It has decreased from 9.90 (Mar 24) to 6.20, marking a decrease of 3.70.
• For PBT Margin (%), as of Mar 25, the value is 5.37. This value is below the healthy minimum of 10. It has decreased from 8.83 (Mar 24) to 5.37, marking a decrease of 3.46.
• For Net Profit Margin (%), as of Mar 25, the value is 3.36. This value is below the healthy minimum of 5. It has decreased from 5.48 (Mar 24) to 3.36, marking a decrease of 2.12.
• For Return on Networth / Equity (%), as of Mar 25, the value is 5.04. This value is below the healthy minimum of 15. It has decreased from 10.03 (Mar 24) to 5.04, marking a decrease of 4.99.
• For Return on Capital Employeed (%), as of Mar 25, the value is 7.35. This value is below the healthy minimum of 10. It has decreased from 13.93 (Mar 24) to 7.35, marking a decrease of 6.58.
• For Return On Assets (%), as of Mar 25, the value is 3.25. This value is below the healthy minimum of 5. It has decreased from 6.12 (Mar 24) to 3.25, marking a decrease of 2.87.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.01. This value is below the healthy minimum of 0.2. It has decreased from 0.04 (Mar 24) to 0.01, marking a decrease of 0.03.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.01. This value is within the healthy range. It has decreased from 0.07 (Mar 24) to 0.01, marking a decrease of 0.06.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.95. It has decreased from 1.11 (Mar 24) to 0.95, marking a decrease of 0.16.
• For Current Ratio (X), as of Mar 25, the value is 1.38. This value is below the healthy minimum of 1.5. It has increased from 1.16 (Mar 24) to 1.38, marking an increase of 0.22.
• For Quick Ratio (X), as of Mar 25, the value is 0.76. This value is below the healthy minimum of 1. It has increased from 0.58 (Mar 24) to 0.76, marking an increase of 0.18.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 8.23. This value exceeds the healthy maximum of 8. It has increased from 3.91 (Mar 24) to 8.23, marking an increase of 4.32.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 33.67. This value is within the healthy range. It has increased from 20.50 (Mar 24) to 33.67, marking an increase of 13.17.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 12.58. This value is below the healthy minimum of 20. It has increased from 11.06 (Mar 24) to 12.58, marking an increase of 1.52.
• For Earning Retention Ratio (%), as of Mar 25, the value is 66.33. This value is within the healthy range. It has decreased from 79.50 (Mar 24) to 66.33, marking a decrease of 13.17.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 87.42. This value exceeds the healthy maximum of 70. It has decreased from 88.94 (Mar 24) to 87.42, marking a decrease of 1.52.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 14.16. This value is within the healthy range. It has increased from 13.61 (Mar 24) to 14.16, marking an increase of 0.55.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 5.02. This value is within the healthy range. It has decreased from 6.12 (Mar 24) to 5.02, marking a decrease of 1.10.
• For Enterprise Value (Cr.), as of Mar 25, the value is 6,955.34. It has increased from 4,073.03 (Mar 24) to 6,955.34, marking an increase of 2,882.31.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.57. This value is within the healthy range. It has increased from 1.28 (Mar 24) to 2.57, marking an increase of 1.29.
• For EV / EBITDA (X), as of Mar 25, the value is 21.66. This value exceeds the healthy maximum of 15. It has increased from 8.76 (Mar 24) to 21.66, marking an increase of 12.90.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.57. This value is within the healthy range. It has increased from 1.26 (Mar 24) to 2.57, marking an increase of 1.31.
• For Retention Ratios (%), as of Mar 25, the value is 66.32. This value is within the healthy range. It has decreased from 79.49 (Mar 24) to 66.32, marking a decrease of 13.17.
• For Price / BV (X), as of Mar 25, the value is 3.86. This value exceeds the healthy maximum of 3. It has increased from 2.31 (Mar 24) to 3.86, marking an increase of 1.55.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.57. This value is within the healthy range. It has increased from 1.26 (Mar 24) to 2.57, marking an increase of 1.31.
• For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. It has decreased from 0.04 (Mar 24) to 0.01, marking a decrease of 0.03.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness